Companies › Merck · Global Markets & Policy
Merck & Co., Inc.
- NYSE: MRK
US drugmaker (known as MSD outside the US and Canada) whose products include the cancer drug Keytruda and vaccines.
Next earnings report: Oct 29, 2026. Merck quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $30.0M, purchases $0. All Merck insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Chirfi Guindo EVP, Access, Policy & Comms | Open-market sale | 10,000 | $135.00 | $1.4M | Form 4 ↗ |
| Aug 12, 2026 | Jennifer Zachary EVP, General Counsel | Open-market sale | 80,315 | $133.46 | $10.7M | Form 4 ↗ |
| Aug 12, 2026 | Richard R. DeLuca EVP&Pres, Merck Animal Heallth | Open-market sale | 11,099 | $131.61 | $1.5M | Form 4 ↗ |
| Aug 12, 2026 | Richard R. DeLuca EVP&Pres, Merck Animal Heallth | Open-market sale | 600 | $132.04 | $79K | Form 4 ↗ |
| Aug 11, 2026 | Richard R. DeLuca EVP&Pres, Merck Animal Heallth | Open-market sale | 7,410 | $131.33 | $973K | Form 4 ↗ |
Key financials
| Metric | FY to Dec 2022 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $59.3B | $60.1B | $64.2B | $65.0B |
| Net income | $14.5B | $365.0M | $17.1B | $18.3B |
| Diluted EPS | $5.71 | $0.14 | $6.74 | $7.28 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-10-13 · 8-K — Director or officer change
- 2026-08-07 · 10-Q
- 2026-08-04 · 8-K — Results of operations
- 2026-05-28 · 8-K — Shareholder vote results
- 2026-05-22 · 8-K — Other events
- 2026-05-04 · 10-Q
- 2026-04-30 · 8-K — Results of operations
- 2026-04-08 · DEF 14A
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.